Vivera Pharmaceuticals scores $440m from JR Dallas Wealth Management

Vivera Pharmaceuticals, a pharmaceutical company, has raised $440 million in funding.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this